These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 6882707)

  • 1. Binding of [3H] monohydroxytamoxifen in ovarian carcinoma.
    Holt JA; Jordan VC; Tate AC; Lorincz MA
    Br J Obstet Gynaecol; 1983 Aug; 90(8):751-8. PubMed ID: 6882707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of [3H] estradiol - and [3H] monohydroxytamoxifen-estrogen receptor complexes with a monoclonal antibody.
    Tate AC; DeSombre ER; Greene GL; Jensen EV; Jordan VC
    Breast Cancer Res Treat; 1983; 3(3):267-77. PubMed ID: 6671136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences between estrogen- and antiestrogen-estrogen receptor complexes from human breast tumors identified with an antibody raised against the estrogen receptor.
    Tate AC; Greene GL; DeSombre ER; Jensen EV; Jordan VC
    Cancer Res; 1984 Mar; 44(3):1012-8. PubMed ID: 6692388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of the radiolabelled high-affinity anti-oestrogen [3H]H1285 with the cytoplasmic oestrogen receptor.
    Keene JL; Sweet F; Ruh MF; Ruh TS
    Biochem J; 1984 Feb; 217(3):819-26. PubMed ID: 6712598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of antibodies to estrogen receptor on the binding of 3H-labeled antiestrogens and androstanediol in the uterus.
    Garcia M; Greene G; Rochefort H; Jensen EV
    Endocrinology; 1982 Apr; 110(4):1355-61. PubMed ID: 7060530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A monohydroxylated metabolite of tamoxifen with potent antioestrogenic activity.
    Jordan VC; Collins MM; Rowsby L; Prestwich G
    J Endocrinol; 1977 Nov; 75(2):305-16. PubMed ID: 591813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study of electrophoretic mobilities of [3H]-estradiol and monohydroxytamoxifen binding components in the cytosols of human breast carcinomas and sera of healthy adult females.
    Raam S; D'Agincourt PG; Jordan VC
    Eur J Cancer Clin Oncol; 1983 Oct; 19(10):1457-65. PubMed ID: 6685632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibody recognition of multiple forms of estrogen receptor tagged with [125I]methoxy-iodovinyl estradiol in ovarian carcinomas.
    Lorincz MA; Holt JA; Greene GL
    J Clin Endocrinol Metab; 1985 Sep; 61(3):412-7. PubMed ID: 4019711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological differences between the estradiol-, tamoxifen- and 4-hydroxy-tamoxifen-estrogen receptor complexes detected by two monoclonal antibodies.
    Giambiagi N; Pasqualini JR
    J Steroid Biochem; 1988; 30(1-6):213-7. PubMed ID: 3386244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the activation of the oestrogen receptor bound to the anti-oestrogens 4-hydroxytamoxifen and ICI 164,384 by using three monoclonal antibodies.
    Giambiagi N; Pasqualini JR
    J Mol Endocrinol; 1991 Aug; 7(1):9-19. PubMed ID: 1892545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple forms of nuclear estrogen receptor in the immature rat uterus after in vitro exchange with [3H]estradiol or [3H] antiestrogens.
    Attardi B
    Mol Cell Endocrinol; 1983 Feb; 29(2):159-67. PubMed ID: 6832469
    [No Abstract]   [Full Text] [Related]  

  • 12. The binding of [3H]-oestradiol-17 beta in the immature rat uterus during the sequential administration of non-steroidal anti-oestrogens.
    Jordan VC; Naylor KE
    Br J Pharmacol; 1979 Feb; 65(2):167-73. PubMed ID: 760895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells.
    Miller MA; Lippman ME; Katzenellenbogen BS
    Cancer Res; 1984 Nov; 44(11):5038-45. PubMed ID: 6488162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of antiestrogens exposes an occult antigenic determinant in the human estrogen receptor.
    Martin PM; Berthois Y; Jensen EV
    Proc Natl Acad Sci U S A; 1988 Apr; 85(8):2533-7. PubMed ID: 2451827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for the metabolic activation of non-steroidal antioestrogens: a study of structure-activity relationships.
    Allen KE; Clark ER; Jordan VC
    Br J Pharmacol; 1980; 71(1):83-91. PubMed ID: 7470748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody-recognized [125I]estradiol-receptor complex in ovarian epithelial carcinoma.
    Holt JA; Lorincz MA; King WJ
    Obstet Gynecol; 1983 Aug; 62(2):231-5. PubMed ID: 6866366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High affinity binding of anti-oestrogen to the chick liver nuclear oestrogen receptor.
    Lazier CB; Jordan VC
    Biochem J; 1982 Aug; 206(2):387-94. PubMed ID: 7150249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of [3H]tamoxifen in rat uterine cytosols: a comparison of swinging bucket and vertical tube rotor sucrose density gradient analysis.
    Jordan VC; Prestwich G
    Mol Cell Endocrinol; 1977 Sep; 8(3):179-88. PubMed ID: 924012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of tamoxifen with cytosolic and nuclear type II estrogen binding sites (type II EBS).
    Ferrandina G; Ranelletti FO; Scambia G; Benedetti Panici P; D'Agostino G; Piantelli M; Isola G; Mancuso S
    Cancer Lett; 1995 Sep; 96(1):123-31. PubMed ID: 7553600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the estrogen receptor and its dynamics in MCF-7 human breast cancer cells using a covalently attaching antiestrogen.
    Monsma FJ; Katzenellenbogen BS; Miller MA; Ziegler YS; Katzenellenbogen JA
    Endocrinology; 1984 Jul; 115(1):143-53. PubMed ID: 6734512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.